<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:mp ids='MP_0001845'>Inflammatory response</z:mp> following <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo>/reperfusion plays a key pathogenic role in ischemic cerebral damage </plain></SENT>
<SENT sid="1" pm="."><plain>Nitric <z:chebi fb="177" ids="25741,29356">oxide</z:chebi> (NO), cyclooxygenase-2 (COX-2) and myeloperoxidase (MPO) are important <z:mp ids='MP_0002501'>inflammatory mediators</z:mp> </plain></SENT>
<SENT sid="2" pm="."><plain>Neuronal NO synthase (nNOS) is a major initial source of excessive NO during <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>/reperfusion </plain></SENT>
<SENT sid="3" pm="."><plain>Induction of COX-2 and infiltration of polymorphonuclear cells expressing MPO are critical factors in delayed inflammatory damage </plain></SENT>
<SENT sid="4" pm="."><plain>Previously, we demonstrated that administration of <z:chebi fb="9" ids="16796">melatonin</z:chebi> before <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> significantly reduced the <z:mpath ids='MPATH_124'>infarct</z:mpath> volume in a rat middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> (MCAO) <z:hpo ids='HP_0001297'>stroke</z:hpo> model </plain></SENT>
<SENT sid="5" pm="."><plain>In this study, we examined the effect of pretreatment with <z:chebi fb="9" ids="16796">melatonin</z:chebi> at 5 mg/kg on the immunoreactivity (ir) for nNOS, COX-2, MPO, and glial fibrillary acidic protein (GFAP) at 24, 48, and 72 hr after right-sided endovascular MCAO for 1 hr in adult male Sprague-Dawley rats </plain></SENT>
<SENT sid="6" pm="."><plain><z:chebi fb="9" ids="16796">Melatonin</z:chebi> did not affect the hemodynamic parameters </plain></SENT>
<SENT sid="7" pm="."><plain>When compared with rats with sham MCAO, <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>/reperfusion led to an ipsilateral increase in cells with positive ir for nNOS (similar at <z:hpo ids='HP_0000001'>all</z:hpo> times) and in ir-GFAP (similar at <z:hpo ids='HP_0000001'>all</z:hpo> times) </plain></SENT>
<SENT sid="8" pm="."><plain><z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">Ischemia</z:e>/reperfusion led to appearance of cells with positive ir for COX-2 (greatest at 24 hr with a tendency to increase again at 72 hr) or MPO (greatest at 24 hr) </plain></SENT>
<SENT sid="9" pm="."><plain>A single dose of <z:chebi fb="9" ids="16796">melatonin</z:chebi> significantly lessened the ipsilateral increase in cells with positive ir for nNOS, COX-2 or MPO, but did not influence the ipsilateral change in ir-GFAP </plain></SENT>
<SENT sid="10" pm="."><plain>Our results suggest that <z:chebi fb="9" ids="16796">melatonin</z:chebi> treatment mediates neuroprotection against <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>/reperfusion injury partly via inhibition of the consequential <z:mp ids='MP_0001845'>inflammatory response</z:mp> </plain></SENT>
</text></document>